Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory.

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

BY DR.Khaled Helmy Chest Specialist Al Mahmora Chest Hospital Ministry of Health - Egypt COPD SCOPE ON.
COPD Chronic Obstructive Lung Disease
EPA’s New Fine Particle Standard & Metropolitan Washington Region Sunil Kumar MWAQC, December 18, 2012 MWCOG Item #3.
COPD Analyses Updated – 7th February February 2011.
EFFECTS OF SMOKING ALLY ZITZMAN TECHNOLOGY AND ASSESSMENT SECTION: 8 AM GEARED TOWARDS HIGH SCHOOL STUDENTS.
นส. นุชนาถ ตั้งเวนิช เจริญสุข รหัส A chronic inflammatory disorder of the airway Airway hyperresponsiveness Recurrent episodes of wheezing,
COPD Health Education COPD Overview Patient Portrayals.
COPD Research at the University of Maryland School of Maryland COPD Clinical Research Center A member of the National Heart Lung & Blood Institute National.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Applied Epidemiology Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) By Chris Callan 23 April 2008.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD Juliana Tambellini University of Pittsburgh.
 Chronic obstructive pulmonary disease (COPD) is one of the most common lung disease  Makes it difficult to breathe  There are two main forms of COPD.
Chronic Lower Respiratory Diseases. Two main Types Discussed Today Chronic Obstructive Pulmonary Disease (COPD) Asthma.
COPD MANAGEMENT FALLS SHORT AT RCRMC Jean Solomon, M.D.
July Darius Computer Skills for the Information Age April 13, 2015.
Faculty Research Advisor: Dr. David Blake. Background Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and.
HIGH DOSES OF VITAMIN D TO REDUCE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED TRIAL An Lehouck, PhD; Chantal Mathieu, MD, PhD;
Emphysema What it is, how you get it, its symptoms, how it is treated, and more. By Carolyn L.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
An International Case Study of Lung Transplantation
RESPIRATORY SYSTEM By Olivia Derivas, Angelina Lin, Anel Mendoza, and Kate Remzso.
HEALTHY CARIBBEAN 2008 Revolutionizing the Prevention and Management of Lung Disease Dr. Timothy Roach FRCP FACP Head, Respiratory Unit Queen Elizabeth.
Chronic Obstructive Pulmonary Disease
By: Hayley Allred, Courtney Zechman, and Amanda Guercioni.
TEMPLATE DESIGN © Prevalence of educational qualifications and access to information technologies in patients with acute.
By Dalia Munoz ASTHMA. is a serious and ongoing disease that affects the airways of both adults and children. Airways are the tubes that carry air in.
WMMC Symposium. Centers For Disease Control What Is Chronic Obstructive Pulmonary Disease (COPD)?  COPD is the name for a group of diseases that restrict.
Commissioning the right COPD care for Londoners 7 November 2011 Royal College of Physicians.
Burden of major Respiratory Diseases WHO Survey Ryazan region of Russia,
Medicines optimisation can help reduce COPD related hospital admissions and exacerbations - LCH MMT Approach Alison McMinn Respiratory Lead Pharmacist.
Risk Assessment Farrokh Alemi, Ph.D.. Session Objectives 1.Discuss the role of risk assessment in the TQM process. 2.Describe the five severity indices.
Chronic Obstructive Pulmonary Disease
The Negative Impact of Air pollution on Respiratory Health Dr Des Murphy Consultant Respiratory Physician CUH.
COPD Diagnosis & Management Anil Ramineni Specialist Respiratory Physiotherapist Community Respiratory Team.
Home Care of Chronic Obstructive Pulmonary Disease Patients.
Chronic Obstructive Pulmonary Disease Austin Paul K.
Respiratory System Disorders. Infectious Diseases  Caused by viruses or bacteria  Bronchitis  Pneumonia  Tuberculosis (TB)  Common Cold.
Airways - ICP launch Dr Mike Bewick Deputy Medical Director NHS England 17 Feb 2014.
Presented by: Bobbie Jo Bennett, Kristen Franklin, & Lacey McGallion
COPD ) ) Chronic Obstructive Pulmonary Disease. Introduction n COPD is a preventable and treatable disease with some significant extrapulmonary effects.
Responsible Respiratory Prescribing
COPD (Chronic Obstructive Pulmonary Disease) By: Montana Martin.
CAPSTONE PROJECT. Setting the scene- why smoking cessation is important in the treatment of COPD.
Asthma Guidelines, Diagnosis and Management Alison Hughes Respiratory Specialist Nurse Solent NHS Trust.
Asthma Lynn Helliwell. Key Facts More than five million people in the UK are being treated for asthma More than five million people in the UK are being.
COPD? Where Are We Headed?
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Spirometry tests were carried out by a Respiratory Clinical Nurse Specialist (Respiratory CNS) Participants were referred to see their General Practitioner.
Chronic Obstructive Pulmonary Disease in the Wessex CLAHRC -Respiratory Theme Dr Lucy Rigge, Clinical Research Fellow Collaboration for Leadership in Applied.
External multicentric validation of a COPD detection questionnaire.
An effective COPD case finding strategy in Primary Care
Respiratory Functions and Diseases
Evidence-based Medicine
COPD- Emphysema & chronic Bronchitis
Medicines Management – COPD update for LPC Jyoti Saini Hema Patel
David Culliford, Lynn Josephs, Matthew Johnson, Mike Thomas
Respiratory Disorders
LUNG DISEASES © 2016 Paul Billiet ODWS.
The Respiratory System
Greater Glasgow Outreach Spirometry Service: A model for closer collaboration between primary and secondary care and its impact on chronic lung disease.
Local Tobacco Control Profiles The webinar will start at 1pm
Asthma and COPD Hannah Bishop Advanced Nurse Practitioner
IoT adoption strategy in a hospital environment
Targeted case finding for chronic obstructive pulmonary disease versus routine practice in primary care (TargetCOPD): a cluster-randomised controlled.
by Shamil Haroon, Peymane Adab, Carl Griffin, and Rachel Jordan
COPD Chronic Obstructive Lung Disease
Screening test accuracy of the final risk score at a threshold of ≥2
COPD Chronic Obstructive Lung Disease
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Presentation transcript:

Identifying COPD in primary care: targeting patients at the highest risk What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory disease of the lungs, primarily caused by cigarette smoking. It includes emphysema and chronic bronchitis and overlaps with asthma. It results in increasing respiratory symptoms such as shortness of breath and in its severe stage can require long-term oxygen therapy. It can have a profound impact on quality of life and often results in premature death. What is COPD? Chronic obstructive pulmonary disease or COPD is a long-term inflammatory disease of the lungs, primarily caused by cigarette smoking. It includes emphysema and chronic bronchitis and overlaps with asthma. It results in increasing respiratory symptoms such as shortness of breath and in its severe stage can require long-term oxygen therapy. It can have a profound impact on quality of life and often results in premature death. The problem COPD is the fifth leading cause of death in the UK. COPD costs the NHS ~£1 billion per year and is a major cause of hospital admissions. Much of the disease burden remains undiagnosed with an estimated 2 million undiagnosed cases in the UK. There is a national drive to identify patients with undiagnosed COPD so that they get better access to the healthcare they need. The problem COPD is the fifth leading cause of death in the UK. COPD costs the NHS ~£1 billion per year and is a major cause of hospital admissions. Much of the disease burden remains undiagnosed with an estimated 2 million undiagnosed cases in the UK. There is a national drive to identify patients with undiagnosed COPD so that they get better access to the healthcare they need. Current smoker Ex-smoker Cough Shortness of breath Wheeze Antibiotics Salbutamol Prednisolone AsthmaChest infection Our solution Developed a risk prediction model that can be used by general practitioners to help identify patients with undiagnosed COPD. Compared risk factors routinely recorded in primary care between 9397 patients with COPD and patients without COPD. We used a statistical method called multiple logistic regression to develop a risk prediction model that incorporates risk factors significantly associated with COPD (see figure- the numbers indicate the size of the association between the risk factor and COPD). We tested the accuracy of the model on a separate group of patients consisting of 4615 with COPD and 8756 without COPD. Accuracy of the model was assessed using a statistic called the area under the receiver operator characteristic curve (or AUC). An AUC of 1 indicates perfect accuracy while an AUC of 0.5 indicates an indiscriminate model. Our model had an AUC of 0.87 which demonstrates a promising ability to identify patients with undiagnosed COPD. Our model could detect up to 80% of patients with undiagnosed COPD. We aim to further develop and validate this model using data from a large randomised controlled trial (Birmingham Lung Improvement Studies, TargetCOPD) Our solution Developed a risk prediction model that can be used by general practitioners to help identify patients with undiagnosed COPD. Compared risk factors routinely recorded in primary care between 9397 patients with COPD and patients without COPD. We used a statistical method called multiple logistic regression to develop a risk prediction model that incorporates risk factors significantly associated with COPD (see figure- the numbers indicate the size of the association between the risk factor and COPD). We tested the accuracy of the model on a separate group of patients consisting of 4615 with COPD and 8756 without COPD. Accuracy of the model was assessed using a statistic called the area under the receiver operator characteristic curve (or AUC). An AUC of 1 indicates perfect accuracy while an AUC of 0.5 indicates an indiscriminate model. Our model had an AUC of 0.87 which demonstrates a promising ability to identify patients with undiagnosed COPD. Our model could detect up to 80% of patients with undiagnosed COPD. We aim to further develop and validate this model using data from a large randomised controlled trial (Birmingham Lung Improvement Studies, TargetCOPD) Application Simple scoring system used by a clinician with or without the aid of software. Incorporation into primary care information systems to estimate COPD risk scores for an entire population. Allow clinicians in primary care to identify patients at high risk of COPD who might benefit from further clinical assessment and treatment. Application Simple scoring system used by a clinician with or without the aid of software. Incorporation into primary care information systems to estimate COPD risk scores for an entire population. Allow clinicians in primary care to identify patients at high risk of COPD who might benefit from further clinical assessment and treatment. Shamil Haroon Rachel Jordan, Tom Marshall, Richard Riley, Robert Lancashire & Peymane Adab. Public Health, Epidemiology & Biostatistics, University of Birmingham